NCT00907764View on ClinicalTrials.gov

Stress Echocardiography Study With Regadenoson

PHASE2TerminatedINTERVENTIONAL

Enrollment

22

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions

Heart DiseaseCoronary Artery Disease

Interventions

DRUG

regadenoson

400 ug, IV

Trial Locations (1)

HA1 3UJ

Northwick Park Hospital, Harrow

Sponsors

Lead Sponsor

Gilead Sciences

All Listed Sponsors

lead

Gilead Sciences

INDUSTRY

NCT00907764 - Stress Echocardiography Study With Regadenoson | Biotech Hunter | Biotech Hunter